Moolec Science Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Dec '20 Dec 31, 2020
Revenue	7.83	5.63	0.91	-	-	-
Revenue Growth (YoY)	170.36%	521.53%	-	-	-	-
Cost of Revenue	8.47	5.15	1.05	-	-	-
Gross Profit	-0.64	0.47	-0.14	-	-	-
Selling, General & Admin	6.86	7.76	5.06	2.63	1.8	0.42
Research & Development	1.59	1.77	1.35	0.99	1.2	0.54
Other Operating Expenses	0.05	-0.02	0.1	0.04	0.19	0.01
Operating Expenses	8.5	9.52	49.22	3.65	3.19	0.96
Operating Income	-9.14	-9.04	-49.36	-3.65	-3.19	-0.96
Interest Expense	-2.18	-1.17	-0.16	-0	-	-
Interest & Investment Income	1.39	1.39	0.69	-	-	-
Earnings From Equity Investments	-0.04	-	-	-	-0.78	-
Currency Exchange Gain (Loss)	-1.12	-3.42	-1.39	-0.01	-	-
Other Non Operating Income (Expenses)	2.2	3.35	0.71	-0.86	-	-
EBT Excluding Unusual Items	-8.91	-8.89	-49.5	-4.53	-3.97	-0.96
Merger & Restructuring Charges	-	-	-3.54	-	-	-
Gain (Loss) on Sale of Investments	0.28	0.53	1.01	-	-	-
Pretax Income	-8.62	-8.36	-52.02	-4.53	-3.97	-0.96
Income Tax Expense	-0.34	-1.05	-0.23	-	-	-
Net Income	-8.28	-7.31	-51.79	-4.53	-3.97	-0.96
Net Income to Common	-8.28	-7.31	-51.79	-4.53	-3.97	-0.96
Shares Outstanding (Basic)	38	38	34	31	30	29
Shares Outstanding (Diluted)	38	38	34	31	30	29
Shares Change (YoY)	1.44%	9.88%	11.18%	2.51%	3.77%	-
EPS (Basic)	-0.22	-0.19	-1.50	-0.15	-0.13	-0.03
EPS (Diluted)	-0.22	-0.19	-1.50	-0.15	-0.13	-0.03
Free Cash Flow	-6.1	-9.49	-7.53	-1.89	1.96	-7.8
Free Cash Flow Per Share	-0.16	-0.25	-0.22	-0.06	0.07	-0.27
Gross Margin	-8.16%	8.40%	-15.83%	-	-	-
Operating Margin	-116.72%	-160.76%	-5453.72%	-	-	-
Profit Margin	-105.72%	-129.99%	-5722.22%	-	-	-
Free Cash Flow Margin	-77.86%	-168.65%	-831.58%	-	-	-
EBITDA	-8.07	-8.16	-49.24	-3.65	-	-
EBITDA Margin	-103.07%	-145.00%	-	-	-	-
D&A For EBITDA	1.07	0.89	0.12	0	-	-
EBIT	-9.14	-9.04	-49.36	-3.65	-3.19	-0.96
EBIT Margin	-116.72%	-160.76%	-	-	-	-

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q